Acting FDA Commissioner Committed to Bringing Biosimilars to Market

Agency providing ‘final guidance’ along pathway Last week, the FDA took significant action toward helping promote competition in the biologic market by providing final guidance on the pathway for “interchangeable” biologics, which may be substituted without the involvement of the prescriber, similar to how…